Serologic response to messenger RNA coronavirus disease 2019 vaccines in inflammatory bowel disease patients receiving biologic therapies
SY Wong, R Dixon, VM Pazos, S Gnjatic… - …, 2021 - gastrojournal.org
Methods All patients were enrolled in the CiTI (COVID-19 in Therapeutic Infusion) study, an
ongoing SARS-CoV-2 serosurvey of IBD patients at the Icahn School of Medicine at Mount
Sinai. All patients who self-reported at least 1 vaccination appointment between the first date
of vaccine distribution in New York City on December 14, 2020 and February 12, 2021 were
included. 7 Specimens were collected at routine infusion center and clinic appointments and
were not timed to vaccination dates. Control groups included 14 completely vaccinated …
ongoing SARS-CoV-2 serosurvey of IBD patients at the Icahn School of Medicine at Mount
Sinai. All patients who self-reported at least 1 vaccination appointment between the first date
of vaccine distribution in New York City on December 14, 2020 and February 12, 2021 were
included. 7 Specimens were collected at routine infusion center and clinic appointments and
were not timed to vaccination dates. Control groups included 14 completely vaccinated …